Report Categories
View AllRecent Articles
View All
Daily Market Overview Dow Nasdaq And Sp 500 Post Modest Broad Gains 20260409 1
Is Semrush Holdings Semr Stock Showing Strength Price At 11.96 Up 0.04 20260406
What Scenarios Affect Jfb Jfb Stock Price Price At 5.67 Down 4.71 20260413
Allogene ALLO Stock Is It Worth Buying Q4 2025 EPS Tops Views
SOJD Southern reports 59 percent Q1 2026 EPS beat shares rise modestly in regular trading
WSFS WSFS posts 12 percent Q1 2026 earnings beat shares rise 115 percent on positive investor sentiment
AGMF Farmer Mac F investors await full performance metrics following its recent quarterly earnings release
Coal Is Fueling Chinas Next Energy Power Play
DMG Blockchain Q2 2026 Earnings Miss Triggers Stock Decline
US Stock Futures and Bond Yields Slide on Reports of Putins Nuclear Doctrine Update
SP 500 MeltUp Scenario Could the Index Reach 8000 or Higher
Honda Accelerates India Expansion Plans 10 New Cars by 2030 Six Launches This Year With New City at Rs 12 Lakh
Berkshire Hathaway Returns to Airlines with 26 Billion Delta Air Lines Stake
SBAC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Leasing Environment
GYRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage
GOOD Q1 2026 Earnings Strong EPS Beat Amid Mixed Sentiment
International Seaways INSW Q1 2026 Earnings Earnings Beat by 476 as Tanker Market Remains Favorable
GENI Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Yet Stock Surges
LDOS Q1 2026 Earnings EPS Beats Estimates by Nearly 6 as Stock Rises
Daktronics DAKT Surges 284 as Shares Approach Resistance Amid Strong Volume
Beyond Air Inc XAIR Holds Near Flatline as Stock Tests Key Support Zone
Encompass Health EHC Gains 116 Approaches Key Resistance Level
SIBONE Inc SIBN Dips 17 as Shares Test Key Support Near 1370
Gladstone Land LAND Shows Modest Uptick as It Approaches Key Resistance Level
PRCT Q1 2026 Earnings NarrowerThanExpected Loss Reflects Operational Discipline
Gentherm Inc THRM Q1 2026 Earnings EPS Crushes Estimates Stock Rises
REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs
MITQ Q1 2026 Earnings Narrowed Loss Reflects Operational Discipline
Immunome Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues